This Is Auburn
Professor emeritus publishes book on sociology of mental health

Professor emeritus publishes book on sociology of mental health

August 08, 2022 @ 9:29 a.m.
facebook logo twitter logo linked in logo

Font Size

A new book by L. Allen Furr, professor emeritus of sociology, explores sociology’s key contributions to the understanding of mental health, providing a counterpoint to the medical approach to the subject.

The Sociology of Mental Health and Illness, published by Sage Publishing in June 2022, uses both micro and macro-level theories to understand the social aspects of mental health and illness. The book shows the subjective nature of mental illness and systems of diagnosis and treatment. It also emphasizes how social conditions and relationships create life pathways toward mental health and psychological struggles and uses the concept of "patient career" to describe how individuals interact with mental health professionals. In addition, the text explores the connections between mental health and social problems such as terrorism, substance abuse, criminal violence, suicide and domestic violence.

Furr’s research focuses on the sociology of health, with a particular interest in mental health. Much of his work has investigated the psychosocial dynamics of facial disfigurement. He was part of the University of Louisville’s research team that pioneered facial transplantation. His work can be found in journals in psychiatry, medicine, nursing, social work, as well as sociology.  Furr was awarded a Fulbright Scholarship to teach at Punjabi University in Patiala, India, and is currently on the Fulbright Specialist Roster.

Allen Furr with cover of his book, The Sociology of Mental Health & Illness

Allen Furr

Categories: Health Sciences


Back to Articles

Related Stories

Get to know Brian Vaughn, an award-winning Auburn University authority on children and peer-relationships

Pharmacy faculty, engineering student find common ground in research collaboration

Auburn University and the University of Massachusetts Medical School team with French Biotech Company to treat neurologic disorder in children